Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–73.
Zolotov Y, Eshet L, Morag O. Preliminary Assessment of Medical Cannabis Consumption by Cancer Survivors. Complement Ther Med. 2021;57:102592.
McLennan A, Kerba M, Subnis U, Campbell T, Carlson LE. Health care provider preferences for, and barriers to, cannabis use in cancer care. Curr Oncol. 2020;27(2):e199-205.
Saadeh CE, Rustem DR. Medical Marijuana Use in a Community Cancer Center. Journal of Oncology Practice. 2018;14(9):e566–78.
Brigden M, England D. Medical marijuana and community oncology practice: the good, the bad, and the potentially ugly. Oncology Exchange. 2018;17(3):10–6.
Daeninck PJ, Maida V. The clinical use of cannabinoid therapies in oncology patients. In: Wedman-St.Louis B, editor. Cannabis : a clinician's guide: Taylor & Francis Group; 2018.
Martell K, Fairchild A, LeGerrier B, Sinha R, Baker S, Liu H, et al. Rates of cannabis use in patients with cancer. Curr Oncol. 2018;25(3):219–25.
Pergam SA, Woodfield MC, Lee CM, Cheng G-S, Baker KK, Marquis SR, et al. Cannabis Use Among Patients at a Comprehensive Cancer Center in a State With Legalized Medicinal and Recreational Use. Cancer. 2017;123(22):4488–97.
Shin S, Mitchell C, Mannion K, Smolyn J, Meghani SH. An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management. Pain Management Nursing. 2018.
Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta- Analysis of Randomized Controlled Trials. Pain Physician. 2017;20(6):E755–96.
Rabgay K, Waranuch N, Chaiyakunapruk N, Swawangjt R, Ingkaninan K, Dilokthornsakul P. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. J Am Pharm Assoc. 2020;60(1):225–34.
Allan G, Finley C, Ton J, Perry D, Ramji J, Crawford K, et al. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms. Can Fam Physician. 2018;64(2):e78–94.
Schussel V, Kenzo L, Santos A, Bueno J, Yoshimura E, Latorraca Oliveira Cruz C, et al. Cannabinoids for nausea and vomiting related to chemotherapy Overview of systematic reviews. Phytotherapy Research. 2018;32:567–76.
Tafelski S, Haüser W, Schäfer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews. Der Schmerz. 2016;30(1):14–24.
Vyas MB, Lebaron VT, Gilson AM. The use of cannabis in response to the opioid crisis: A review of the literature. Nurs Outlook. 2018;66(1):56–65.
Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy. 2018;52:87–96.
Steele G, Arneson T, Zylla D. A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. Curr Oncol Rep. 2019;21(10):1–12.
Brown D, Watson M, Schloss J. Pharmacological evidence of medicinal cannabis in oncology: a systematic review. Support Care Cancer. 2019;27(9):3195–207.
Sawtelle L, Holle LM. Use of Cannabis and Cannabinoids in Patients With Cancer. Ann Pharmacother. 2021;57(7):870–90.
Martinasek MP, McGrogan JB, Maysonet A. A Systematic Review of the Respiratory Effects of Inhalational Marijuana. Respir Care. 2016;61(11):1543–51.
Memedovich KA, Dowsett LE, Spackman E, Noseworthy T, Clement F. The adverse health effects and harms related to marijuana use: an overview review. CMAJ Open. 2018;6(3):E339–46.
Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: A systematic review and meta-analysis. J Affect Disord. 2015;171:39–47.
Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med. 2014;44(4):797–810.
Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophr Bull. 2016;42(5):1262–9.
Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review. Biol Psychiat. 2016;79(7):557–67.
Cohen K, Weinstein A. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review. Brain Sci. 2018;8(40):1–19.
Nader DA. Sanchez ZM. Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults. 2017;44(1):1–15.
Scott JC, Slomiak ST, Jones JD, Rosen AF, Moore TM, Gur RC. Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults A Systematic Review and Meta-analysis. JAMA Psychiat. 2018;75(6):585–95.
Balneaves LG, Alraja A, Ziemianski D, McCuaig F, Ware M. A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes. Cannabis and Cannabinoid Research. 2018;3(1):66–73.
Clark CS. Medical Cannabis: The oncology nurse’s role in patient education about the effects of marijuana on cancer palliation. Clin J Oncol Nurs. 2018;22(1):E1–6.
Gardiner KM, Singleton JA, Sheridan J, Kyle GJ, Nissen LM. Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis - A systematic review. PLoS One. 2019;14(5):e0216556.
Corroon J, Sexton M, Bradley R. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Family Practice. 2019;20:1–12.
Kaplan L, Klein T, Wilson MG, Graves J. Knowledge, Practices, and Attitudes of Washington State Health Care Professionals Regarding Medical Cannabis. Cannabis and Cannabinoid Research. 2020;5(2):172–82.
Smith LA, Azariah F, Lavender VT, Stoner NS, Beltiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews. 2015(11).
Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: Evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020;34(4):444–53.
Darkovska-Serafimovska M, Serafimovska T, Arsova-Sarafinovska Z, Stefanoski S, Keskovski Z, Balkanov T. Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. J Pain Res. 2018;11:837–42.
Wang J, Wang Y, Tong M, Pan H, Li D. Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis. BioMed Research International. 2019.
Joanna Briggs Institute. Chapter 11: Scoping reviews 2020 [Available from: https://wiki.jbi.global/display/MANUAL/Chapter+11%3A+Scoping+reviews.
Tricco AC, Lillie E, Zrin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–73.
Miles MB, Huberman AM, Saldaña J. Qualitative data analysis: A methods sourcebook. 3rd ed. Thousand Oaks, Californie: SAGE Publications Inc.; 2014.
Loiselle CG, Howell D, Nicoll I, Fitch M. Toward the development of a comprehensive cancer experience measurement framework. Support Care Cancer. 2019;27:2579–89.
Bertrand A, Boyle H, Moreaux J, Guillot L, Chvetzoff G, Charbonnel J-F, et al. Does consumption of tobacco, alcohol, and cannabis in adolescents and young adults with cancer affect the use of analgesics during hospitalizations? Arch Pediatr. 2016;23(4):353–9.
National Comprehensive Cancer Network. Antiemesis - Version 1.2021 2021 [Available from: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.
Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(28):3240–61.
Peñas De las R, Blasco A, De Castro J, Escobar Y, García-Campelo R, Gúrpide A, et al. SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016). Clinical and Translational Oncology. 2016;18:1237–42.
Elliott DA, Nabavizadeh N, Romer JL, Chen Y, Holland JM. Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. Support Care Cancer. 2016;24(8):3517–24.
Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM. Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida. Journal of Palliative Medicine. 2019;22(10):1202–7.
Turcott JG, del Rocío Guillen Núñez M, Flores-Estrada D, Oñate-Ocaña LF, Zatarain-Barrón ZL, Barrón F, et al. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients a randomized, double-blind clinical trial. Supportive Care in Cancer. 2018;26(9):3029–38.
Anderson SP, Zylla DM, McGriff DM, Arneson TJ. Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program. Journal of Oncology Practice. 2019;15(4):e338–45.
Fallon MT, Lux EA, McQuade R, Rossetti S, Sanchez R, Sun W, et al. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain. 2017;11(3):119–33.
Good P, Haywood A, Gogna G, Martin J, Yates P, Greer R, et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a doubleblind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC Palliative Care. 2019;187(1):1–7.
Highet BH, Lesser ER, Johnson PW, Kaur JS. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population. Am J Hosp Palliat Med. 2020;37(8):589–93.
Kim A, Kaufmann CN, Ko R, Li Z, Han BH. Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State. J Palliat Care. 2019;22(10):1196–201.
Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M. Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. Journal of Supportive Oncology. 2008;6(3):119–24.
Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, et al. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ Open. 2020;8(9):e020745.
Singh V, Zarrabi AJ, Curseen KA, Sniecinski R, Welsh JW, McKenzie-Brown AM, et al. Concerns of Patients With Cancer on Accessing Cannabis Products in a State With Restrictive Medical Marijuana Laws: A Survey Study. Journal of Oncology Practice. 2019;15(10):531–8.
Taha T, Meiri D, Talhamy S, Wollner M, Peer A, Bar-Sela G. Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies. Oncologist. 2019;24(4):549–54.
Wilson MM, Masterson E, Broglio K. Cannabis Use among Patients in a Rural Academic Palliative Care Clinic. J Palliat Med. 2019;22(10):1224–6.
Zarrabi AJ, Welsh JW, Sniecinski R, Curseen K, Gillespie T, Baer W, et al. Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice. J Palliat Med. 2020;23(4):558–62.
Drosdowsky A, Blaschke S, Koproski T, Fullerton S, Thackerar A, Ellen S, et al. Cancer patients’ use of and attitudes towards medicinal cannabis. Aust Health Rev. 2020;44(4):650–5.
Luckett T, Phillips J, Allsop D, Lee J, Solowij N, Martin J, et al. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation. Intern Med J. 2016;46(11):1269–75.
Tanco K, Dumlao D, Kreis R, Nguyen K, Dibaj S, Liu D, et al. Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State. J Palliat Med. 2019;22(10):1213–20.
Yeshurun M, Shpilberg O, Herscovici CLS, Dreyer J, Peck A, et al. Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation Results of a Phase II Study. Biology of Blood and Marrow Transplantation. 2015;21(10):1770–5.
Lintzeris N, Mills L, Suraev A, Bravo M, Arkell T, Arnold JC, et al. Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross- Sectional Cannabis as Medicine Survey (CAMS-18). Harm Reduction Journal. 2020;17(37):1–12.
Bar-Sela G, Tauber D, Mitnik I, Sheinman-Yuffe H, Bishara-Frolova T, Aharon-Peretz J. Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. Anticancer Drugs. 2019;30(1):91–7.
Bar-Sela G, Vorobeichik M, Drawsheh S, Omer A, Goldberg V, Muller E. The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care. Evidence-based Complementary and Alternative Medicine. 2013;2013:1–8.
Bar-Sela G, Zalman D, Semenysty V, Ballan E. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Integr Cancer Ther. 2019;18:1–8.
Birdsall SM, Birdsall TC, Tims LA. The Use of Medical Marijuana in Cancer. Curr Oncol Rep. 2016;18(40):1–9.
Braun IM, Nayak MM, Revette A, Wright AA, Chai PR, Yusufov M, et al. Cancer Patients’ Experiences With Medicinal Cannabis-Related Care. Cancer. 2020;127(1):67–73.
Buchwald D, Brønnum D, Melgaard D, Leutscher PDC. Living with a Hope of Survival Is Challenged by a Lack of Clinical Evidence: An Interview Study among Cancer Patients Using Cannabis-Based Medicine. J Palliat Med. 2020;23(8):1090–3.
Byars T, Theisen E, Bolton DL. Using Cannabis to Treat Cancer-Related Pain. Semin Oncol Nurs. 2019;35(3):300–9.
Cheng K-C, Li Y-X, Cheng J-T. The Use of Herbal Medicine in Cancer-related Anorexia/Cachexia Treatment Around the World. Curr Pharm Des. 2012;18(31):4810–26.
Donovan KA, Portman DG. Effect of COVID-19 Pandemic on Cannabis Use in Cancer Patients. Journal of Hospice and Palliative Medicine. 2021;38(7):850–3.
Good PD, Greer RM, Huggett GE, Hardy JR. An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care. J Palliat Med. 2020;23(5):650–5.
Hall W, Christie M, Currow D. Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncology. 2005;6(1):35–42.
Haüser W, Welsch P, Klose P, Radbruch L, Fitzcharles MA. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain A systematic review with meta-analysis of randomised controlled trials. Der Schmerz. 2019;33:424–36.
Hawley P, Gobbo M. Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada. Curr Oncol. 2019;26(4):e425–32.
Huskey A. Cannabinoids in cancer pain management. J Pain Palliat Care Pharmacother. 2006;20(3):43–6.
Keller R. Medical Cannabis in Cancer Care. Radiat Ther. 2020;29(1):55–71.
Kleckner AS, Kleckner IR, Kamen CS, Tejani MA, Janelsins MC, Morrow GR, et al. Opportunities for cannabis in supportive care in cancer. Therapeutic Advances in Medical Oncology. 2019;11:1–29.
LeClair JN, Chamberlin KW, Clement J, Holle LM. Documentation of medical marijuana use in cancer patients. J Oncol Pharm Pract. 2020;26(5):1117–27.
Likar R, Nahler G. The use of cannabis in supportive care and treatment of brain tumor. Neuro-Oncology Practice. 2017;4(3):151–60.
Lossignol D. Cannabinoids: a new approach for pain control? Curr Opin Oncol. 2019;31(4):275–9.
Panozzo S, Le B, Collins A, Weil J, Whyte J, Barton M, et al. Who is asking about medicinal cannabis in palliative care? Intern Med J. 2020;50(2):243–6.
Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Social Adm Pharm. 2016;12(4):638–54.
Pawasarat IM, Schultz EM, Frisby JC, Mehta S, Angelo MA, Hardy SS, et al. The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain. J Palliat Med. 2020;23(6):809–16.
Podda M, Pagani Bagliacca E, Sironi G, Veneroni L, Silva M, Angi M, et al. Cannabinoids use in adolescents and young adults with cancer: a single-center survey. Tumori Journal. 2020;106(4):281–5.
Potts JM, Getachew B, Vu M, Nehl E, Yeager KA, Leach CR, et al. Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors. Journal of Cancer Education. 2020.
Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001;178(2):107–15.
Rosewall T, Feuz C, Bayley A. Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials. Journal of Medical Imaging and Radiation Sciences. 2020;51(2):342–9.
Trentham K. Medical Cannabis: Considerations for Dietitians Working in Oncology. Oncology Nutrition Connection. 2017;20(2):34–43.
Turgeman I, Bar-Sela G. Cannabis for cancer–illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opin Investig Drugs. 2019;28(3):285–96.
Victorson D, McMahon M, Horowitz B, Glickson S, Parker B, Mendoza-Temple L. Exploring cancer survivors’ attitudes, perceptions, and concerns about using medical cannabis for symptom and side effect management: A qualitative focus group study. Complement Ther Med. 2019;47:102204.
Waissengrin B, Urban D, Leshem Y, Garty M, Wolf I. Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience. J Pain Symptom Manage. 2015;49(2):223–30.
Walsh C, Currin-McCulloch J, Simon P, Zebrack B, Jones BA. Shifting Needs and Preferences: Supporting Young Adult Cancer Patients During the Transition from Active Treatment to Survivorship Care. J Adolesc Young Adult Oncol. 2019;8(2):114–21.
Wang J, Wang Y, Tong M, Pan H, Li D. New Prospect for Cancer Cachexia: Medical Cannabinoid. J Cancer. 2019;10(3):716–20.
Ware MA, Daeninck P, Maida V. A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. Ther Clin Risk Manag. 2008;4(1):99–107.
Welliver M. Cannabinoid agonists for nausea and vomiting. Gastroenterol Nurs. 2016;39(2):137–8.
Wilson A, Davis C. Attitudes of Cancer Patients to Medicinal Cannabis Use: A Qualitative Study. Australian Social Work. 2021.
Zalman D, Bar-Sela G. Cannabis and synthetic cannabinoids for cancer patients: Multiple palliative indications together with promising laboratory antineoplastic effects. In: Preedy VR, editor. Handbook of cannabis and related pathologies: Biology, pharmacology, diagnosis, and treatment. San Diego, CA, US: Elsevier Academic Press; 2017. p. 859–68.
Zhou G, Stoltzfus JC, Houldin AD, Parks SM, Swan BA. Knowledge, Attitudes, and Practice Behaviors of Oncology Advanced Practice Nurses Regarding Advanced Care Planning for Patients With Cancer. Oncol Nurs Forum. 2010;37(6):E400–10.
Donovan KA, Oberoi-Jassal R, Chang YD, Rajasekhara S, Haas MF, Randich AL, et al. Cannabis Use in Young Adult Cancer Patients. J Adolesc Young Adult Oncol. 2020;9(1):30–5.
Bar-Lev Schleider L, Mechoulam R, Lederman V, Hilou M, Lencovsky O, Betzalel O, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med. 2018;49:37–43.
Brisbois TD, de Hock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol. 2011;22(9):2086–93.
Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167–79.
Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol. 2006;24(21):3394–400.
JL Kramer 2015 Medical marijuana for cancer. CA: a cancer journal for clinicians. 65 2 109 22
Maida V, Daeninck PJ. A user’s guide to cannabinoid therapies in oncology. Curr Oncol. 2016;23(6):398–406.
Meng H, Dai T, Hanlon JG, Downar J, Alibhai SM, Clarke H. Cannabis and cannabinoids in cancer pain management. Current Opinion in Supportive Palliative Care. 2020;14(2):87–93.
Karim S, Cheung WY, Bu J, Jess E, Kerba M. Medical Cannabis Authorization in Patients With Cancer in the Prelegalization Era: A Population-Based Study. J Pain Symptom Manage. 2020;59(6):1223–31.
Milam J, Slaughter R, Meeske K, Ritt-Olson A, Sherman-Bien S, Freyer DR, et al. Substance use among adolescent and young adult cancer survivors. Psychooncology. 2017;25(11):1357–62.
Poghosyan H, Poghosyan A. Marijuana use among cancer survivors: Quantifying prevalence and identifying predictors. Addictive Behaviors. 2021;112:106634.
Machado Rocha FC, Stéfano SC, De Cassia HR, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care. 2008;17(5):431–43.
Amato L, Davoli M, Minozzi S, Mitrova Z, Parmelli E, Saulle R, et al. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy 2016 [Available from: https://www.who.int/medicines/access/controlled-substances/Systematic_reviews_on_therapeutic_efficacy_and_safety.pdf?ua=1.
Campbell FA, Tramer MR, Carroll D, Reynolds DJM, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ. 2001;323:1–6.
Gouveia DN, Guimarães AG, Santos WBDR, Quintans-Júnior LJ. Natural products as a perspective for cancer pain management: A systematic review. Phytomedicine. 2019;58:152766.
Mucke M, Weier M, Carter C, Copeland J, Degenhardt L, Cuhls H, et al. Systematic review and meta-analysis of cannabinoids in palliative medicine. J Cachexia Sarcopenia Muscle. 2018;9:220–34.
Tallant J. Cannabinoids for the treatment of cancer-related pain: a systematic review. Cancer Nursing Practice. 2020;19(2):37–42.
van den Beuken-van Everdingen MHJ, de Graeff A, Jongen JLM, Dijkstra D, Mostovaya I, Vissers KC. Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review. Pain Pract. 2017;17(3):409–19.
Tateo S. State of the evidence: Cannabinoids and cancer pain-A systematic review. J Am Assoc Nurse Pract. 2017;29(2):94–103.
Häuser W, Welsch P, Klose P, Radbruch L, Fitzcharles M-A. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain: A systematic review with meta-analysis of randomised controlled trials. Schmerz. 2019;33(5):424–36.
Phillips KT, Phillips MM, Lalonde TL, Prince MA. Does social context matter? An ecological momentary assessment study of marijuana use among college students. Addict Behav. 2018;83:154–9.
Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy J-P, Rueda S, et al. Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education. Cannabis and Cannabinoid Research. 2019;4(3):204–13.
Bruce D, Bouris AM, Bowers S, Blocker O, Young Lee S, Glidden MF, et al. Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV. Addiction Research & Theory. 2020;28(3):250–9.
Davis MP. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. Expert Opin Investig Drugs. 2008;17(1):85–95.
Zaki P, Blake A, Wolt A, Chan S, Liying Z, Wan A, et al. The use of medical cannabis in cancer patients. Journal of Pain Management. 2017;10(4):353–62.
Zhang H, Xie M, Archibald SD, Jackson BS, Gupta MK. Association of marijuana use with psychosocial and quality of life outcomes among patients with head and neck cancer. JAMA Otolaryngology-head & Neck Surgery. 2018;144(11):1017–22.
Donovan KA, Chang YD, Oberoi-Jassal R, Rajasekhara S, Smith J, Haas M, et al. Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. J Palliat Med. 2019;22(10):1191–5.
Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics. J Pain Symptom Manage. 2013;46(2):207–18.
Webster EM, Yadav GS, Gysler S, McNamara B, Black J, Tymon-Rosario J, et al. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study. Gynecologic Oncology Reports. 2020;34:100667.
Government of Canada. Cannabis Act (S.C. 2018, c. 16) 2020 [Available from: https://laws-lois.justice.gc.ca/eng/acts/c-24.5/.
MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12–9.
Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, et al. Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study. J Clin Oncol. 2018;36(19):1957–62.
Sannes TS, Nayak MM, Tung S, et al. United States oncologists’ clinical preferences regarding modes of medicinal cannabis use. Cancer Commun. 2021;41(6):528–31.
Corroon J, Sexton M, Bradley R. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Family Practice. 2019;20(174):1–12.